|
|
Volumn 40, Issue 9, 2001, Pages 547-550
|
|
Lyme borreliosis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMOXICILLIN;
ANTIINFECTIVE AGENT;
AZITHROMYCIN;
BACTERIAL VACCINE;
BACTERIUM ANTIBODY;
CEFOTAXIME;
CEFTRIAXONE;
CEFUROXIME AXETIL;
CEPHALOSPORIN DERIVATIVE;
DOXYCYCLINE;
ERYTHROMYCIN;
MACROLIDE;
MINOCYCLINE;
PENICILLIN G;
PENICILLIN G DERIVATIVE;
PENICILLIN V;
RECOMBINANT OUTER SURFACE PROTEIN A;
TETRACYCLINE;
TETRACYCLINE DERIVATIVE;
UNCLASSIFIED DRUG;
ACRODERMATITIS;
ALLERGY;
ANTIBIOTIC PROPHYLAXIS;
ANTIBIOTIC SENSITIVITY;
ANTIMICROBIAL THERAPY;
BORRELIA BURGDORFERI;
CLINICAL FEATURE;
CLINICAL TRIAL;
DIFFERENTIAL DIAGNOSIS;
DISEASE COURSE;
DISEASE TRANSMISSION;
DRUG EFFICACY;
DRUG SAFETY;
ERYTHEMA CHRONICUM MIGRANS;
HISTOPATHOLOGY;
HUMAN;
IMMUNOFLUORESCENCE TEST;
IMMUNOPATHOLOGY;
INFLAMMATORY DISEASE;
LYME DISEASE;
LYMPHOCYTOMA;
NONHUMAN;
PRACTICE GUIDELINE;
PREGNANCY;
PREVALENCE;
REVIEW;
SIDE EFFECT;
SKIN DISCOLORATION;
TICK BITE;
TOOTH DISEASE;
VACCINATION;
DIAGNOSIS, DIFFERENTIAL;
HUMANS;
LYME DISEASE;
|
|
EID: 0035186652
PISSN: 00119059
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-4362.2001.01236.x Document Type: Review |
|
Times cited : (8)
|
|
References (14)
|
